Candida endocarditis and the impact of antifungal treatment on the corrected QT interval: a case report
- 60 Downloads
Candida endocarditis represents a life-threatening infection with high mortality rates despite adequate antifungal treatment. Step-down oral treatment with fluconazole or voriconazole represents a treatment option for clinically stable patients. Drug toxicity, however, is reported during azole therapy and can be challenging, especially among patients with multiple comorbidities. This is the first report that highlights the impact of isavuconazole on the corrected QT interval and liver toxicity in a cirrhotic patient with Candida endocarditis.
Compliance with ethical standards
Informed written consent was obtained from the patient for the publication of this case report.
Conflict of interest
All authors declare that they have no potential conflicts of interest.
No specific funding was received.
- 1.Lefort A, Chartier L, Sendid B, et al; On behalf of the French Mycosis Study Group. Diagnosis, management and outcome of Candida endocarditis. Clin Microbiol Infect. 2012;18(4):E99–E109.Google Scholar